世界の腫瘍マーカーイムノアッセイ市場：市場規模・現状・予測

• 英文タイトル：Global Tumor Markers Immunoassay Market Size, Status and Forecast 2019-2025

• レポートコード：QYR9N8148
• 出版社/出版日：QYResearch / 2019年6月14日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、103ページ
• 納品方法：Eメール（受注後２～3営業日）
• 産業分類：医療・製薬・バイオ

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Enterprise License	￥1,154,400 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

当資料は、腫瘍マーカーイムノアッセイのグローバル市場について調査・分析したレポートで、種類別（ProGRP、PSA（複合型、無料、合計））、SCC（扁平上皮がん抗原）、血清HER-2 / neu、チログロブリン、その他）、用途別（肝臓がん、乳がん、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。

・腫瘍マーカーイムノアッセイの世界市場規模
・主要企業別市場シェア
・腫瘍マーカーイムノアッセイの世界市場規模：種類別（ProGRP、PSA（複合型、無料、合計））、SCC（扁平上皮がん抗原）、血清HER-2 / neu、チログロブリン、その他）
・腫瘍マーカーイムノアッセイの世界市場規模：用途別（肝臓がん、乳がん、その他）
・腫瘍マーカーイムノアッセイのアメリカ市場規模（種類別、用途別）
・腫瘍マーカーイムノアッセイのヨーロッパ市場規模（種類別、用途別）
・腫瘍マーカーイムノアッセイの中国市場規模（種類別、用途別）
・腫瘍マーカーイムノアッセイの日本市場規模（種類別、用途別）
・腫瘍マーカーイムノアッセイの東南アジア市場規模（種類別、用途別）
・腫瘍マーカーイムノアッセイのインド市場規模（種類別、用途別）
・腫瘍マーカーイムノアッセイの中南米市場規模（種類別、用途別）
・主要企業別分析（企業概要、製品動向、販売量など）
・腫瘍マーカーイムノアッセイの世界市場予測（2019年-2025年）
・腫瘍マーカーイムノアッセイの地域別市場予測（2019年-2025年）
...

In 2018, the global Tumor Markers Immunoassay market size was million US$ and it is expected to reach million US$ by the end of 2025, with a CAGR of during 2019-2025.
This report focuses on the global Tumor Markers Immunoassay status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Tumor Markers Immunoassay development in United States, Europe and China.

The key players covered in this study
Clarity Diagnostics, LLC
CTK Biotech, Inc
DIALAB GmbH
Ortho Clinical Diagnostics
Polymedco, Inc
DIAsource ImmunoAssays SA
DRG International, Inc
Fujirebio US, Inc
Bioscience (Tianjin) Diagnostic Technology Co., Ltd
Boson Biotech Co., Ltd
Qualigen, Inc
Randox Laboratories, Ltd
Roche Diagnostic Corporation
Siemens Healthineers
Syntron Bioresearch, Inc
Teco Diagnostics
Thermo Fisher Scientific, Inc
Tosoh Bioscience, Inc
Diametra
DiaSorin S.p.A

Market segment by Type, the product can be split into
ProGRP
PSA (complexed, free, total))
SCC (squamous cell carcinoma antigen)
Serum HER-2/neu
Thyroglobulin
CA 72-4
Others

Market segment by Application, split into
Liver Cancer
Breast Cancer
Others

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Tumor Markers Immunoassay status, future forecast, growth opportunity, key market and key players.
To present the Tumor Markers Immunoassay development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Tumor Markers Immunoassay are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

レポート目次

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Tumor Markers Immunoassay Market Size Growth Rate by Type (2014-2025)
1.4.2 ProGRP
1.4.3 PSA (complexed, free, total))
1.4.4 SCC (squamous cell carcinoma antigen)
1.4.5 Serum HER-2/neu
1.4.6 Thyroglobulin
1.4.7 CA 72-4
1.4.8 Others
1.5 Market by Application
1.5.1 Global Tumor Markers Immunoassay Market Share by Application (2014-2025)
1.5.2 Liver Cancer
1.5.3 Breast Cancer
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Tumor Markers Immunoassay Market Size
2.2 Tumor Markers Immunoassay Growth Trends by Regions
2.2.1 Tumor Markers Immunoassay Market Size by Regions (2014-2025)
2.2.2 Tumor Markers Immunoassay Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Tumor Markers Immunoassay Market Size by Manufacturers
3.1.1 Global Tumor Markers Immunoassay Revenue by Manufacturers (2014-2019)
3.1.2 Global Tumor Markers Immunoassay Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Tumor Markers Immunoassay Market Concentration Ratio (CR5 and HHI)
3.2 Tumor Markers Immunoassay Key Players Head office and Area Served
3.3 Key Players Tumor Markers Immunoassay Product/Solution/Service
3.4 Date of Enter into Tumor Markers Immunoassay Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Tumor Markers Immunoassay Market Size by Type (2014-2019)
4.2 Global Tumor Markers Immunoassay Market Size by Application (2014-2019)

5 United States
5.1 United States Tumor Markers Immunoassay Market Size (2014-2019)
5.2 Tumor Markers Immunoassay Key Players in United States
5.3 United States Tumor Markers Immunoassay Market Size by Type
5.4 United States Tumor Markers Immunoassay Market Size by Application

6 Europe
6.1 Europe Tumor Markers Immunoassay Market Size (2014-2019)
6.2 Tumor Markers Immunoassay Key Players in Europe
6.3 Europe Tumor Markers Immunoassay Market Size by Type
6.4 Europe Tumor Markers Immunoassay Market Size by Application

7 China
7.1 China Tumor Markers Immunoassay Market Size (2014-2019)
7.2 Tumor Markers Immunoassay Key Players in China
7.3 China Tumor Markers Immunoassay Market Size by Type
7.4 China Tumor Markers Immunoassay Market Size by Application

8 Japan
8.1 Japan Tumor Markers Immunoassay Market Size (2014-2019)
8.2 Tumor Markers Immunoassay Key Players in Japan
8.3 Japan Tumor Markers Immunoassay Market Size by Type
8.4 Japan Tumor Markers Immunoassay Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Tumor Markers Immunoassay Market Size (2014-2019)
9.2 Tumor Markers Immunoassay Key Players in Southeast Asia
9.3 Southeast Asia Tumor Markers Immunoassay Market Size by Type
9.4 Southeast Asia Tumor Markers Immunoassay Market Size by Application

10 India
10.1 India Tumor Markers Immunoassay Market Size (2014-2019)
10.2 Tumor Markers Immunoassay Key Players in India
10.3 India Tumor Markers Immunoassay Market Size by Type
10.4 India Tumor Markers Immunoassay Market Size by Application

11 Central & South America
11.1 Central & South America Tumor Markers Immunoassay Market Size (2014-2019)
11.2 Tumor Markers Immunoassay Key Players in Central & South America
11.3 Central & South America Tumor Markers Immunoassay Market Size by Type
11.4 Central & South America Tumor Markers Immunoassay Market Size by Application

12 International Players Profiles
12.1 Clarity Diagnostics, LLC
12.1.1 Clarity Diagnostics, LLC Company Details
12.1.2 Company Description and Business Overview
12.1.3 Tumor Markers Immunoassay Introduction
12.1.4 Clarity Diagnostics, LLC Revenue in Tumor Markers Immunoassay Business (2014-2019)
12.1.5 Clarity Diagnostics, LLC Recent Development
12.2 CTK Biotech, Inc
12.2.1 CTK Biotech, Inc Company Details
12.2.2 Company Description and Business Overview
12.2.3 Tumor Markers Immunoassay Introduction
12.2.4 CTK Biotech, Inc Revenue in Tumor Markers Immunoassay Business (2014-2019)
12.2.5 CTK Biotech, Inc Recent Development
12.3 DIALAB GmbH
12.3.1 DIALAB GmbH Company Details
12.3.2 Company Description and Business Overview
12.3.3 Tumor Markers Immunoassay Introduction
12.3.4 DIALAB GmbH Revenue in Tumor Markers Immunoassay Business (2014-2019)
12.3.5 DIALAB GmbH Recent Development
12.4 Ortho Clinical Diagnostics
12.4.1 Ortho Clinical Diagnostics Company Details
12.4.2 Company Description and Business Overview
12.4.3 Tumor Markers Immunoassay Introduction
12.4.4 Ortho Clinical Diagnostics Revenue in Tumor Markers Immunoassay Business (2014-2019)
12.4.5 Ortho Clinical Diagnostics Recent Development
12.5 Polymedco, Inc
12.5.1 Polymedco, Inc Company Details
12.5.2 Company Description and Business Overview
12.5.3 Tumor Markers Immunoassay Introduction
12.5.4 Polymedco, Inc Revenue in Tumor Markers Immunoassay Business (2014-2019)
12.5.5 Polymedco, Inc Recent Development
12.6 DIAsource ImmunoAssays SA
12.6.1 DIAsource ImmunoAssays SA Company Details
12.6.2 Company Description and Business Overview
12.6.3 Tumor Markers Immunoassay Introduction
12.6.4 DIAsource ImmunoAssays SA Revenue in Tumor Markers Immunoassay Business (2014-2019)
12.6.5 DIAsource ImmunoAssays SA Recent Development
12.7 DRG International, Inc
12.7.1 DRG International, Inc Company Details
12.7.2 Company Description and Business Overview
12.7.3 Tumor Markers Immunoassay Introduction
12.7.4 DRG International, Inc Revenue in Tumor Markers Immunoassay Business (2014-2019)
12.7.5 DRG International, Inc Recent Development
12.8 Fujirebio US, Inc
12.8.1 Fujirebio US, Inc Company Details
12.8.2 Company Description and Business Overview
12.8.3 Tumor Markers Immunoassay Introduction
12.8.4 Fujirebio US, Inc Revenue in Tumor Markers Immunoassay Business (2014-2019)
12.8.5 Fujirebio US, Inc Recent Development
12.9 Bioscience (Tianjin) Diagnostic Technology Co., Ltd
12.9.1 Bioscience (Tianjin) Diagnostic Technology Co., Ltd Company Details
12.9.2 Company Description and Business Overview
12.9.3 Tumor Markers Immunoassay Introduction
12.9.4 Bioscience (Tianjin) Diagnostic Technology Co., Ltd Revenue in Tumor Markers Immunoassay Business (2014-2019)
12.9.5 Bioscience (Tianjin) Diagnostic Technology Co., Ltd Recent Development
12.10 Boson Biotech Co., Ltd
12.10.1 Boson Biotech Co., Ltd Company Details
12.10.2 Company Description and Business Overview
12.10.3 Tumor Markers Immunoassay Introduction
12.10.4 Boson Biotech Co., Ltd Revenue in Tumor Markers Immunoassay Business (2014-2019)
12.10.5 Boson Biotech Co., Ltd Recent Development
12.11 Qualigen, Inc
12.12 Randox Laboratories, Ltd
12.13 Roche Diagnostic Corporation
12.14 Siemens Healthineers
12.15 Syntron Bioresearch, Inc
12.16 Teco Diagnostics
12.17 Thermo Fisher Scientific, Inc
12.18 Tosoh Bioscience, Inc
12.19 Diametra
12.20 DiaSorin S.p.A

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Tables and Figures

Table Tumor Markers Immunoassay Key Market Segments
Table Key Players Tumor Markers Immunoassay Covered
Table Global Tumor Markers Immunoassay Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Tumor Markers Immunoassay Market Size Market Share by Type 2014-2025
Figure ProGRP Figures
Table Key Players of ProGRP
Figure PSA (complexed, free, total)) Figures
Table Key Players of PSA (complexed, free, total))
Figure SCC (squamous cell carcinoma antigen) Figures
Table Key Players of SCC (squamous cell carcinoma antigen)
Figure Serum HER-2/neu Figures
Table Key Players of Serum HER-2/neu
Figure Thyroglobulin Figures
Table Key Players of Thyroglobulin
Figure CA 72-4 Figures
Table Key Players of CA 72-4
Figure Others Figures
Table Key Players of Others
Table Global Tumor Markers Immunoassay Market Size Growth by Application 2014-2025 (Million US$)
Figure Liver Cancer Case Studies
Figure Breast Cancer Case Studies
Figure Others Case Studies
Figure Tumor Markers Immunoassay Report Years Considered
Table Global Tumor Markers Immunoassay Market Size 2014-2025 (Million US$)
Figure Global Tumor Markers Immunoassay Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Tumor Markers Immunoassay Market Size by Regions 2014-2025 (Million US$)
Table Global Tumor Markers Immunoassay Market Size by Regions 2014-2019 (Million US$)
Table Global Tumor Markers Immunoassay Market Share by Regions 2014-2019
Figure Global Tumor Markers Immunoassay Market Share by Regions 2014-2019
Figure Global Tumor Markers Immunoassay Market Share by Regions 2019
Table Market Top Trends
Table Global Tumor Markers Immunoassay Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Tumor Markers Immunoassay Market Share by Manufacturers (2014-2019)
Figure Global Tumor Markers Immunoassay Market Share by Manufacturers in 2018
Table Global Tumor Markers Immunoassay Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Tumor Markers Immunoassay Product/Solution/Service
Table Date of Enter into Tumor Markers Immunoassay Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Tumor Markers Immunoassay Market Size by Type (2014-2019) (Million US$)
Table Global Tumor Markers Immunoassay Market Size Share by Type (2014-2019)
Figure Global Tumor Markers Immunoassay Market Size Market Share by Type (2014-2019)
Table Global Tumor Markers Immunoassay Market Size by Application (2014-2019) (Million US$)
Table Global Tumor Markers Immunoassay Market Size Share by Application (2014-2019)
Figure Global Tumor Markers Immunoassay Market Size Market Share by Application (2014-2019)
Figure Global Tumor Markers Immunoassay Revenue Market Share by Application in 2018
Figure United States Tumor Markers Immunoassay Market Size 2014-2019 (Million US$)
Table United States Key Players Tumor Markers Immunoassay Revenue (2018-2019) (Million US$)
Table United States Key Players Tumor Markers Immunoassay Market Share (2018-2019)
Table United States Tumor Markers Immunoassay Market Size by Type (2014-2019) (Million US$)
Table United States Tumor Markers Immunoassay Market Share by Type (2014-2019)
Table United States Tumor Markers Immunoassay Market Size by Application (2014-2019) (Million US$)
Table United States Tumor Markers Immunoassay Market Share by Application (2014-2019)
Figure Europe Tumor Markers Immunoassay Market Size 2014-2019 (Million US$)
Table Europe Key Players Tumor Markers Immunoassay Revenue (2018-2019) (Million US$)
Table Europe Key Players Tumor Markers Immunoassay Market Share (2018-2019)
Table Europe Tumor Markers Immunoassay Market Size by Type (2014-2019) (Million US$)
Table Europe Tumor Markers Immunoassay Market Share by Type (2014-2019)
Table Europe Tumor Markers Immunoassay Market Size by Application (2014-2019) (Million US$)
Table Europe Tumor Markers Immunoassay Market Share by Application (2014-2019)
Figure China Tumor Markers Immunoassay Market Size 2014-2019 (Million US$)
Table China Key Players Tumor Markers Immunoassay Revenue (2018-2019) (Million US$)
Table China Key Players Tumor Markers Immunoassay Market Share (2018-2019)
Table China Tumor Markers Immunoassay Market Size by Type (2014-20189) (Million US$)
Table China Tumor Markers Immunoassay Market Share by Type (2014-2019)
Table China Tumor Markers Immunoassay Market Size by Application (2014-2019) (Million US$)
Table China Tumor Markers Immunoassay Market Share by Application (2014-2019)
Figure Japan Tumor Markers Immunoassay Market Size 2014-2019 (Million US$)
Table Japan Key Players Tumor Markers Immunoassay Revenue (2018-2019) (Million US$)
Table Japan Key Players Tumor Markers Immunoassay Market Share (2018-2019)
Table Japan Tumor Markers Immunoassay Market Size by Type (2014-2019) (Million US$)
Table Japan Tumor Markers Immunoassay Market Share by Type (2014-2019)
Table Japan Tumor Markers Immunoassay Market Size by Application (2014-2019) (Million US$)
Table Japan Tumor Markers Immunoassay Market Share by Application (2014-2019)
Figure Southeast Asia Tumor Markers Immunoassay Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Tumor Markers Immunoassay Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Tumor Markers Immunoassay Market Share (2018-2019)
Table Southeast Asia Tumor Markers Immunoassay Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Tumor Markers Immunoassay Market Share by Type (2014-2019)
Table Southeast Asia Tumor Markers Immunoassay Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Tumor Markers Immunoassay Market Share by Application (2014-2019)
Figure India Tumor Markers Immunoassay Market Size 2014-2019 (Million US$)
Table India Key Players Tumor Markers Immunoassay Revenue (2018-2019) (Million US$)
Table India Key Players Tumor Markers Immunoassay Market Share (2018-2019)
Table India Tumor Markers Immunoassay Market Size by Type (2014-2019) (Million US$)
Table India Tumor Markers Immunoassay Market Share by Type (2014-2019)
Table India Tumor Markers Immunoassay Market Size by Application (2014-2019) (Million US$)
Table India Tumor Markers Immunoassay Market Share by Application (2014-2019)
Figure Central & South America Tumor Markers Immunoassay Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Tumor Markers Immunoassay Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Tumor Markers Immunoassay Market Share (2018-2019)
Table Central & South America Tumor Markers Immunoassay Market Size by Type (2014-2019) (Million US$)
Table Central & South America Tumor Markers Immunoassay Market Share by Type (2014-2019)
Table Central & South America Tumor Markers Immunoassay Market Size by Application (2014-2019) (Million US$)
Table Central & South America Tumor Markers Immunoassay Market Share by Application (2014-2019)
Table Clarity Diagnostics, LLC Company Details
Table Clarity Diagnostics, LLC Revenue in Tumor Markers Immunoassay Business (2014-2019) (Million US$)
Figure Clarity Diagnostics, LLC Revenue Growth Rate in Tumor Markers Immunoassay Business (2014-2019)
Table Clarity Diagnostics, LLC Recent Development
Table CTK Biotech, Inc Company Details
Table CTK Biotech, Inc Revenue in Tumor Markers Immunoassay Business (2014-2019)(Million US$)
Figure CTK Biotech, Inc Revenue Growth Rate in Tumor Markers Immunoassay Business (2014-2019)
Table CTK Biotech, Inc Recent Development
Table DIALAB GmbH Company Details
Table DIALAB GmbH Revenue in Tumor Markers Immunoassay Business (2014-2019)(Million US$)
Figure DIALAB GmbH Revenue Growth Rate in Tumor Markers Immunoassay Business (2014-2019)
Table DIALAB GmbH Recent Development
Table Ortho Clinical Diagnostics Company Details
Table Ortho Clinical Diagnostics Revenue in Tumor Markers Immunoassay Business (2014-2019)(Million US$)
Figure Ortho Clinical Diagnostics Revenue Growth Rate in Tumor Markers Immunoassay Business (2014-2019)
Table Ortho Clinical Diagnostics Recent Development
Table Polymedco, Inc Company Details
Table Polymedco, Inc Revenue in Tumor Markers Immunoassay Business (2014-2019)(Million US$)
Figure Polymedco, Inc Revenue Growth Rate in Tumor Markers Immunoassay Business (2014-2019)
Table Polymedco, Inc Recent Development
Table DIAsource ImmunoAssays SA Company Details
Table DIAsource ImmunoAssays SA Revenue in Tumor Markers Immunoassay Business (2014-2019)(Million US$)
Figure DIAsource ImmunoAssays SA Revenue Growth Rate in Tumor Markers Immunoassay Business (2014-2019)
Table DIAsource ImmunoAssays SA Recent Development
Table DRG International, Inc Company Details
Table DRG International, Inc Revenue in Tumor Markers Immunoassay Business (2014-2019)(Million US$)
Figure DRG International, Inc Revenue Growth Rate in Tumor Markers Immunoassay Business (2014-2019)
Table DRG International, Inc Recent Development
Table Fujirebio US, Inc Company Details
Table Fujirebio US, Inc Revenue in Tumor Markers Immunoassay Business (2014-2019)(Million US$)
Figure Fujirebio US, Inc Revenue Growth Rate in Tumor Markers Immunoassay Business (2014-2019)
Table Fujirebio US, Inc Recent Development
Table Bioscience (Tianjin) Diagnostic Technology Co., Ltd Company Details
Table Bioscience (Tianjin) Diagnostic Technology Co., Ltd Revenue in Tumor Markers Immunoassay Business (2014-2019)(Million US$)
Figure Bioscience (Tianjin) Diagnostic Technology Co., Ltd Revenue Growth Rate in Tumor Markers Immunoassay Business (2014-2019)
Table Bioscience (Tianjin) Diagnostic Technology Co., Ltd Recent Development
Table Boson Biotech Co., Ltd Company Details
Table Boson Biotech Co., Ltd Revenue in Tumor Markers Immunoassay Business (2014-2019)(Million US$)
Figure Boson Biotech Co., Ltd Revenue Growth Rate in Tumor Markers Immunoassay Business (2014-2019)
Table Boson Biotech Co., Ltd Recent Development
Table Qualigen, Inc Company Details
Table Randox Laboratories, Ltd Company Details
Table Roche Diagnostic Corporation Company Details
Table Siemens Healthineers Company Details
Table Syntron Bioresearch, Inc Company Details
Table Teco Diagnostics Company Details
Table Thermo Fisher Scientific, Inc Company Details
Table Tosoh Bioscience, Inc Company Details
Table Diametra Company Details
Table DiaSorin S.p.A Company Details
Table Global Tumor Markers Immunoassay Market Size by Regions (Million US$) 2019-2025
Figure Global Tumor Markers Immunoassay Market Size Share by Regions (2019-2025)
Figure Global Tumor Markers Immunoassay Market Size Share by Regions in 2025
Figure United States Tumor Markers Immunoassay Market Size Forecast (2019-2025)(Million USD)
Figure Europe Tumor Markers Immunoassay Market Size Forecast (2019-2025)(Million USD)
Figure China Tumor Markers Immunoassay Market Size Forecast (2019-2025)(Million USD)
Figure Japan Tumor Markers Immunoassay Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Tumor Markers Immunoassay Market Size Forecast (2019-2025)(Million USD)
Figure India Tumor Markers Immunoassay Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Tumor Markers Immunoassay Market Size Forecast (2019-2025)(Million USD)
Table Global Tumor Markers Immunoassay Market Size by Product (2019-2025) (Million US$)
Figure Global Tumor Markers Immunoassay Market Size by Product (2019-2025)
Figure Global Tumor Markers Immunoassay Market Size by Product in 2025
Table Global Tumor Markers Immunoassay Market Size by Application (2019-2025) (Million US$)
Figure Global Tumor Markers Immunoassay Market Size by Application (2019-2025)
Figure Global Tumor Markers Immunoassay Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

以下、関連資料のご紹介

世界の腫瘍マーカー検査市場：市場規模・現状・予測

Global Tumor Marker Testing Market Size, Status and Forecast 2019-2025
QYR9N8147 2019年6月14日 94Pages
当資料は、腫瘍マーカー検査のグローバル市場について調査・分析したレポートで、種類別（生化学マーカー、がん遺伝子、成長因子、ホルモン、コロニー刺激因子、その他）、用途別（病院、商業/民間研究所、医師のオフィス/グループプラクティス、がんクリニック、外来治療センター）、主要地域別（アメリカ、ヨーロッパ、...

世界の一重免疫測定法市場：市場規模・現状・予測

Global Singleplex Immunoassay Market Size, Status and Forecast 2019-2025
QYR9N8041 2019年6月14日 92Pages
当資料は、一重免疫測定法のグローバル市場について調査・分析したレポートで、種類別（タンパク質ベースのアッセイ、核酸ベースのアッセイ、細胞ベースのアッセイ、その他）、用途別（病院および研究機関、リファレンス研究所、製薬およびバイオテクノロジー企業、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本...

世界の腫瘍治療フィールド（TTFields）市場：市場規模・現状・予測

Global Tumor Treating Fields (TTFields) Market Size, Status and Forecast 2019-2025
QYR9N8149 2019年6月14日 94Pages
当資料は、腫瘍治療フィールド（TTFields）のグローバル市場について調査・分析したレポートで、種類別（低周波、中間周波数）、用途別（病院、診療所、がんおよび放射線療法センター、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報な...

世界の転移性脊髄腫瘍市場：市場規模・現状・予測

Global Metastases Spinal Tumor Market Size, Status and Forecast 2019-2025
QYR9N7549 2019年6月14日 95Pages
当資料は、転移性脊髄腫瘍のグローバル市場について調査・分析したレポートで、種類別（硬膜外、その他）、用途別（病院と診療所、外来手術センター、学術機関、研究センター、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれていま...

世界の小児脳腫瘍市場：市場規模・現状・予測

Global Pediatric Brain Tumor Market Size, Status and Forecast 2019-2025
QYR9N7778 2019年6月14日 92Pages
当資料は、小児脳腫瘍のグローバル市場について調査・分析したレポートで、種類別（神経膠腫、神経膠腫の混合腫瘍、胚性腫瘍、脈絡叢乳頭腫/がん、非神経上皮組織から発生する腫瘍、その他）、用途別（病院と診療所、医学研究センター、学術機関）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中...

世界の性腺生殖腺間質腫瘍の治療市場：市場規模・現状・予測

Global Sex Cord Gonadal Stromal Tumor Treatment Market Size, Status and Forecast 2019-2025
QYR9N8025 2019年6月14日 93Pages
当資料は、性腺生殖腺間質腫瘍の治療のグローバル市場について調査・分析したレポートで、種類別（化学療法、放射線療法、手術、その他）、用途別（病院、診療所、がん研究センター、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれ...

世界の性索性腺間質腫瘍市場：市場規模・現状・予測

Global Sex Cord Gonadal Stromal Tumor Market Size, Status and Forecast 2019-2025
QYR9N8024 2019年6月14日 104Pages
当資料は、性索性腺間質腫瘍のグローバル市場について調査・分析したレポートで、種類別（診断、治療）、用途別（病院での使用、診療所での使用、研究センター、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。

世界の腫瘍バイオマーカー検査市場：市場規模・現状・予測

Global Tumor Biomarker Test Market Size, Status and Forecast 2019-2025
QYR9N8146 2019年6月14日 91Pages
当資料は、腫瘍バイオマーカー検査のグローバル市場について調査・分析したレポートで、種類別（前立腺特異抗原検査、CTCテスト、アルファフェトプロテイン（AFP）試験、CAテスト、HER2テスト、その他）、用途別（肺がん、乳がん、結腸直腸、前立腺がん、血液がん）、主要地域別（アメリカ、ヨーロッパ、中国、...

世界のイムノアッセイ市場：市場規模・現状・予測

Global Immunoassays Market Size, Status and Forecast 2019-2025
QYR9N7340 2019年6月14日 98Pages
当資料は、イムノアッセイのグローバル市場について調査・分析したレポートで、種類別（酵素免疫測定法、蛍光イムノアッセイ、化学発光イムノアッセイ、ラジオイムノアッセイ、比濁イムノアッセイ）、用途別（病院、集中ラボ、研究機関、製薬およびバイオテクノロジー会社、受託研究機関）、主要地域別（アメリカ、ヨーロッ...

世界のウィルムス腫瘍治療市場2019

Global Wilms' Tumor Treatment Sales Market Report 2019
QYR9N5732 2019年6月14日 106Pages
本調査レポートでは、ウィルムス腫瘍治療の世界市場について調査・分析し、ウィルムス腫瘍治療のメーカー別販売量、市場シェア分析、種類別販売分析（カボサンチニブ、SEL-12034、ラコツモマブ、その他）、用途別販売分析（病院、診療所、その他）、地域別販売分析（米国、ヨーロッパ、中国、日本、東南アジア、イ...

世界の頭頸部治療の扁平上皮がん市場：市場規模・現状・予測 Head and neck cancer usually occurs in the squamous cells present inside the mouth, nose and throat. These squamous cells are usually known as squamous cell carcinoma of the head and neck.In 2018, the global Squamous Cell Carcinoma of the Head and Neck Treatment market size was xx million US$ and it…
世界の一重免疫測定法市場：市場規模・現状・予測 Singleplex immunoassays such as Enzyme-Linked Immunosorbent Assays (ELISA) or western blotting are used sequentially to analyze multiple intracellular and extracellular proteins. Moreover, singleplex immunoassay provides a fast and high-through output solution for gene expression quantification.The …
世界の腫瘍マーカー検査市場：市場規模・現状・予測 The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, and unlock the mystery of the genetic basis of the disease.During the next five years, the worldwide cancer diagno…
世界の腫瘍バイオマーカー検査市場：市場規模・現状・予測 In 2018, the global Tumor Biomarker Test market size was million US$ and it is expected to reach million US$ by the end of 2025, with a CAGR of during 2019-2025. This report focuses on the global Tumor Biomarker Test status, future forecast, growth opportunity, key market and key players. The study …
世界の腫瘍治療フィールド（TTFields）市場：市場規模・現状・予測 Tumor Treating Field (TTField) is an anticancer treatment which disrupts the tumor cells mitosis. Tumor Treating Field is a low intensity technique which disrupts the division of cells through physical interaction of molecules during mitosis in tumor cancer.North America is projected to hold largest…